Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: an article on the 10Q - "future licensing activity"
14
Oct 15, 2013 04:33PM
3
Oct 15, 2013 06:11PM

At least they bought back nearly half million shares in September/October.

At this rate they could lower the float to 370 million in ten years. Thanks for pointing out this positive event.


Oct 16, 2013 02:49AM
Share
New Message
Please login to post a reply